Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued TreatmentCongenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Malformations of Cortical Development, Group I, Neoplasms, Multiple Primary, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, central nervous system malformation, cerebral cortical dysplasia, hamartoma, hereditary disease, hereditary neoplastic syndrome, inherited neurodegenerative disorder, neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, tuberous sclerosis, visual epilepsyActive, not recruitingPhase 32026-08-21NCT02962414

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Novartis Pharmaceuticals432

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Atlantic Health Morristown MCMorristownUnited States1
Childrens Hospital Of PhiladelphiaPhiladelphiaUnited States18
Cinn Children Hosp Medical CenterCincinnatiUnited States10
Connecticut Childrens Medical CntrHartfordUnited States1
David Geffen School of Medicine at UCLALos AngelesUnited States1
Minnesota Epilepsy GroupSaint PaulUnited States1
Oregon Health Sciences UniversityPortlandUnited States33
Rady Children s HospitalSan DiegoUnited States2
Texas Childrens HospitalHoustonUnited States12
Texas Scottish Rite Hos for ChildDallasUnited States1
TGen APNNAPhoenixUnited States1
UCSF Benioff Children s HospitalOaklandUnited States2
University of Chicago Medical CenterChicagoUnited States152
University of Colorado School of MedicineAuroraUnited States12